Venetoclax combination studies showing great promise at ASH 2017
Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment
Making an IMPACT in ALL therapy: how can cure rates be improved?
Primary analysis of MURANO study data for R/R CLL
Myeloma XI trial: impact of MRD on treatment response in MM